Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis

Abstract

Diagnostics require precision and predictive ability to be clinically useful. Integration of multi-omic with clinical data is crucial to our understanding of disease pathogenesis and diagnosis. However, interpretation of overwhelming amounts of information at the individual level requires sophisticated computational tools for extraction of clinically meaningful outputs. Moreover, evolution of technical and analytical methods often outpaces standardisation strategies. RNA is the most dynamic component of all -omics technologies carrying an abundance of regulatory information that is least harnessed for use in clinical diagnostics. Gene expression-based tests capture genetic and non-genetic heterogeneity and have been implemented in certain diseases. For example patients with early breast cancer are spared toxic unnecessary treatments with scores based on the expression of a set of genes (e.g., Oncotype DX). The ability of transcriptomics to portray the transcriptional status at a moment in time has also been used in diagnosis of dynamic diseases such as sepsis. Gene expression profiles identify endotypes in sepsis patients with prognostic value and a potential to discriminate between viral and bacterial infection. The application of transcriptomics for patient stratification in clinical environments and clinical trials thus holds promise. In this review, we discuss the current clinical application in the fields of cancer and infection. We use these paradigms to highlight the impediments in identifying useful diagnostic and prognostic biomarkers and propose approaches to overcome them and aid efforts towards clinical implementation.

Group Heteroscedasticity - A Silent Saboteur of Power and False Discovery in RNA-Seq Differential Expression

“…Naturally, RNA-Seq has emerged as a universal and established technology in modern biology over the last decade or so for unraveling the molecular basis of biological processes 9,8 , as highlighted by increasingly common translational and clinical studies utilizing transcriptome profiling across a variety of disease areas and therapeutic outcomes 37,26,60,69,42,22 . Diverse applications of RNA-Seq include patient stratification, disease subtype identification, biomarker discovery, and mechanism of action study, among others 17,63 .…”

Systems Biology in Cancer Diagnosis Integrating Omics Technologies and Artificial Intelligence to support physician decision-making

“…These approaches do not provide information on the molecular alterations that precede and follow the onset of cancer. Molecular and omics technologies can provide a genetic, epigenetic, and metabolic profile of the tumor that can better define such alterations thus helping to determine the most appropriate treatment as well as predict the response to therapy [9,10].…”